Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01472159 · ClinicalTrials.gov registry record · NA

Can Glucose Monitoring Improve (CGMi Study)

A NA study of Type 1 Diabetes, sponsored by Joslin Diabetes Center.

Completed
Registry status
NA
Development phase
130
Enrollment target
1
Study location

NCT01472159: Completed NA study of Type 1 Diabetes, sponsored by Joslin Diabetes Center.

NCT01472159 is a NA study of Type 1 Diabetes that has completed, run by Joslin Diabetes Center. The registered enrollment target is 130 participants, below the 766-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01472159, a NA study of Type 1 Diabetes, has completed, sponsored by Joslin Diabetes Center.

COMPLETED
Registry status
NA
Development phase
130 participants
Enrollment target
1
Study location

Study Summary

The purpose of this 2-year randomized controlled trial (RCT) is to implement and evaluate a family-focused behavioral teamwork intervention aimed at overcoming barriers to sustained continuous glucose monitoring (CGM) use in youth with type 1 diabetes (T1D). We hypothesize that CGM implemented with a family-focused, behavioral teamwork intervention will result in sustained CGM use and greater improvement in A1c compared to routine implementation of CGM.

Conditions Studied

Interventions

  • BEHAVIORAL CGM Family Teamwork Intervention

Study Locations (1)

Massachusetts

  • Joslin Diabetes Center - Boston

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2011-10
Est. Completion 2015-08
Phase NA
Joslin Diabetes Center

73 total trials

What the finished NCT01472159 record still lists

NCT01472159 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 766-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (83% lower).

The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which CGM Family Teamwork Intervention is the first listed.

NCT01472159 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01472159 about?

NCT01472159 is a clinical study titled "Can Glucose Monitoring Improve (CGMi Study)". The purpose of this 2-year randomized controlled trial (RCT) is to implement and evaluate a family-focused behavioral teamwork intervention aimed at overcoming barriers to sustained continuous glucose monitoring (CGM) use in youth with type 1 diabetes (T1D). We hypothesize that CGM implemented with ...

What is the current status of trial NCT01472159?

This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2011-10. Estimated completion is 2015-08.

What conditions does trial NCT01472159 study?

This clinical trial studies the following conditions: Type 1 Diabetes.

What interventions are being tested in trial NCT01472159?

The interventions under investigation include: CGM Family Teamwork Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01472159?

This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01472159 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01472159's enrollment target sits among peer trials

130 43rd of 198 higher than 155 of 198 other Type 1 Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Type 1 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01492036 · 130 participants

    Long-Term Follow-Up of Recipient of Gene Transfer Research

  • NCT01631617 · 130 participants · Phase 2

    Effects of Treatments on Atopic Dermatitis

  • NCT02368041 · 130 participants

    Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure

  • NCT02604277 · 130 participants · NA

    Suicidal Behavior in Patients Diagnosed With Bipolar Disorder

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01472159, the US trial registry maintained by the National Library of Medicine. NCT01472159 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.